EMBC
Embecta Corp
NASDAQ: EMBC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$3.90
-57.84% today
Updated 2026-05-05
Market cap
$547.78M
P/E ratio
3.92
P/S ratio
0.51x
EPS (TTM)
$2.36
Dividend yield
6.50%
52W range
$4 – $15
Volume
1.1M
Embecta Corp (EMBC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | $745.00M | $738.00M | $788.00M | $1.09B | $1.21B | $1.29B | $1.09B |
| Cash & equivalents | — | — | $0.00 | $330.90M | $326.30M | $267.50M | $225.50M |
| Current assets | $248.00M | $235.00M | $292.00M | $664.70M | $749.10M | $761.00M | $631.40M |
| Total liabilities | $126.00M | $166.00M | $194.00M | $1.98B | $2.04B | $2.02B | $1.74B |
| Current liabilities | $126.00M | $137.00M | $164.00M | $301.00M | $353.50M | $374.00M | $261.50M |
| Long-term debt | — | — | — | $1.60B | $1.59B | $1.57B | $1.39B |
| Shareholder equity | $577.00M | $572.00M | $594.00M | $-891.40M | $-821.70M | $-738.30M | $-650.60M |
| Retained earnings | — | — | $0.00 | $-577.10M | $-541.10M | $-498.60M | $-445.60M |
| Accounts receivable | $127.00M | $120.00M | $150.60M | $23.40M | $17.90M | $248.00M | $148.90M |
| Inventory | $101.00M | $102.00M | $118.00M | $122.80M | $152.10M | $171.50M | $178.60M |
| Goodwill | $16.00M | $16.00M | $16.00M | $15.70M | $15.60M | $15.60M | $15.40M |